Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment Options for Motor and Non-Motor Symptoms of Parkinson’s Disease
Frank Church
Biomolecules (2021) Vol. 11, Iss. 4, pp. 612-612
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Neurogenesis in aging and age-related neurodegenerative diseases
Luka Čulig, Xixia Chu, Vilhelm A. Bohr
Ageing Research Reviews (2022) Vol. 78, pp. 101636-101636
Open Access | Times Cited: 117
New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson’s disease
Rohan Gupta, Smita Kumari, Anusha Senapati, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102013-102013
Closed Access | Times Cited: 55
Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 19
A Comprehensive Approach to Parkinson’s Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects
Mauricio Muleiro Álvarez, Gabriela Cano-Herrera, María Fernanda Osorio Martínez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7183-7183
Open Access | Times Cited: 16
Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives
Virendra Kumar Yadav, Seshathiri Dhanasekaran, Nisha Choudhary, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 2
SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 37-56
Open Access | Times Cited: 68
Sensitive immunosensing of α-synuclein protein in human plasma samples using gold nanoparticles conjugated with graphene: an innovative immuno-platform towards early stage identification of Parkinson's disease using point of care (POC) analysis
Esmaeil Darvish Aminabad, Ahmad Mobed, Mohammad Hasanzadeh, et al.
RSC Advances (2022) Vol. 12, Iss. 7, pp. 4346-4357
Open Access | Times Cited: 45
Current Treatments and New, Tentative Therapies for Parkinson’s Disease
Teresa Pardo-Moreno, Victoria García‐Morales, Nora Suleiman‐Martos, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 770-770
Open Access | Times Cited: 39
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Yaser Hosny Ali Elewa, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2743-2759
Open Access | Times Cited: 38
The Promise of Niacin in Neurology
Emily Wuerch, Gloria Roldan Urgoiti, V. Wee Yong
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 1037-1054
Open Access | Times Cited: 32
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Paramita Saha‐Chaudhuri, Himanshu Kathuria, Murali Monohar Pandey
Journal of Controlled Release (2023) Vol. 358, pp. 293-318
Closed Access | Times Cited: 30
Green Synthesis of Sulfur- and Nitrogen-Doped Carbon Quantum Dots for Determination of L-DOPA Using Fluorescence Spectroscopy and a Smartphone-Based Fluorimeter
Amir Hemmati, Hamid Emadi, Seyed Reza Nabavi
ACS Omega (2023) Vol. 8, Iss. 23, pp. 20987-20999
Open Access | Times Cited: 28
Role of Brain Liver X Receptor in Parkinson’s Disease: Hidden Treasure and Emerging Opportunities
Saud A. Alnaaim, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 341-357
Open Access | Times Cited: 28
Parkinson’s Disease and Photobiomodulation: Potential for Treatment
Brian Bicknell, Ann Liebert, Geoffrey Herkes
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 112-112
Open Access | Times Cited: 12
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 11
Ensemble Machine Learning Approach for Parkinson’s Disease Detection Using Speech Signals
Syed Nisar Hussain Bukhari, Kingsley A. Ogudo
Mathematics (2024) Vol. 12, Iss. 10, pp. 1575-1575
Open Access | Times Cited: 11
Combating Parkinson’s Disease with Plant-Derived Polyphenols: Targeting Oxidative Stress and Neuroinflammation
Reem M. Gahtani, Shoaib Shoaib, Umme Hani, et al.
Neurochemistry International (2024) Vol. 178, pp. 105798-105798
Closed Access | Times Cited: 10
Salivary Biomarkers for Parkinson’s Disease: A Systematic Review with Meta-Analysis
Kacper Nijakowski, Wojciech Owecki, Jakub Jankowski, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 340-340
Open Access | Times Cited: 9
From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care
Masaru Tanaka
Biomedicines (2025) Vol. 13, Iss. 1, pp. 167-167
Open Access | Times Cited: 1
Clinical perspective on pluripotent stem cells derived cell therapies for the treatment of neurodegenerative diseases
Michal Izrael, Judith Chebath, Kfir Molakandov, et al.
Advanced Drug Delivery Reviews (2025), pp. 115525-115525
Closed Access | Times Cited: 1
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Anamaria Jurcău, Felicia Liana Andronie-Cioară, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14582-14582
Open Access | Times Cited: 22
The potential role of cholesterol in Parkinson’s disease neuropathology: perpetrator or victim
Mohammed Alrouji, Hayder M. Al‐kuraishy, Abdul-karim Abd Ali Al-Mahammadawy, et al.
Neurological Sciences (2023) Vol. 44, Iss. 11, pp. 3781-3794
Closed Access | Times Cited: 18
Care access and utilization among medicare beneficiaries living with Parkinson’s disease
Caroline Pearson, Alex Hartzman, Dianne Munevar, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Cell-therapy for Parkinson’s disease: a systematic review and meta-analysis
Fang Wang, Zhengwu Sun, Daoyong Peng, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Regulation of mitophagy and mitochondrial function: Natural compounds as potential therapeutic strategies for Parkinson's disease
Hao Liang, Zhenwang Ma, Wei Zhong, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 4, pp. 1838-1862
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top